1. Home
  2. BNR vs XGN Comparison

BNR vs XGN Comparison

Compare BNR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$18.73

Market Cap

126.5M

Sector

Health Care

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$8.39

Market Cap

110.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
XGN
Founded
2014
2002
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.5M
110.7M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
BNR
XGN
Price
$18.73
$8.39
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $8.86
AVG Volume (30 Days)
60.4K
★ 244.0K
Earning Date
06-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$2.59
52 Week High
$41.72
$12.23

Technical Indicators

Market Signals
Indicator
BNR
XGN
Relative Strength Index (RSI) 69.89 63.35
Support Level $15.61 $4.08
Resistance Level $18.59 N/A
Average True Range (ATR) 1.75 0.39
MACD 0.53 0.01
Stochastic Oscillator 81.45 76.70

Price Performance

Historical Comparison
BNR
XGN

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: